The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia

NCT ID: NCT07017881

Last Updated: 2025-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-05

Study Completion Date

2024-10-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to investigate the effects of Psychosocial Skills Training on subjective recovery, self-esteem and quality of life levels of schizophrenia patients. The research is a randomized controlled trial. The research was conducted with 48 schizophrenia patients (Experimental: 24, Control: 24) registered in the Mental Health and Diseases Outpatient Clinic of a hospital. Personal Information Form, Subjective Recovery Assessment Scale, Rosenberg Self-Esteem Scale, Quality of Life Scale for Schizophrenia Patients were used to collect data. Data were collected by the researcher using the self-reporting face-to-face interview method in the form of pre-test and post-test. Psychosocial Skills Training was applied to the patients in the experimental group, one session per week, two days a week for 11 weeks, while the patients in the control group did not receive any intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophenia Disorder Psychiatric Nursing Psychosocial Skills Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The sample group was determined as 48 in total, 24 intervention and 24 control. Individuals were assigned to the intervention and control groups using the simple randomization method. The program was asked to randomly divide the files into two groups of 24 people each. The researcher randomly determined these two groups as the intervention (Set 1) and control (Set 2) groups. The 24 individuals constituting the intervention group were assigned to 3 separate groups of 8 people each (Group 1, Group 2, Group 3) using the block randomization method. In addition to their routine treatments, the intervention group received one session of psychosocial skills training per week. The control group continued their routine treatments.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

No intervention was applied. They continued their routine outpatient clinic check-ups and treatments.

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention group

The intervention group is a group of 24 schizophrenia patients who received 11 weeks of Psychosocial Skills Training.

Group Type EXPERIMENTAL

Psychosocial Skills Training

Intervention Type BEHAVIORAL

The 24-person intervention group was divided into three separate groups of 8 people (Group 1, Group 2, Group 3). Group 1 and Group 2 attended sessions on Tuesdays at different times, while Group 3 attended sessions on Thursdays. Psychosocial Skills Training consisted of eleven sessions in total, one session per week. Sessions lasted an average of 60 minutes for each group. In each session, 5-10 minute breaks were given for rest and eating and drinking, considering the attention span and fatigue of the patients. Psychosocial Skills Training was applied two days a week (Group 1-2: Tuesday, Group 3: Thursday) in order to ensure that the patients could get more benefit from the application.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychosocial Skills Training

The 24-person intervention group was divided into three separate groups of 8 people (Group 1, Group 2, Group 3). Group 1 and Group 2 attended sessions on Tuesdays at different times, while Group 3 attended sessions on Thursdays. Psychosocial Skills Training consisted of eleven sessions in total, one session per week. Sessions lasted an average of 60 minutes for each group. In each session, 5-10 minute breaks were given for rest and eating and drinking, considering the attention span and fatigue of the patients. Psychosocial Skills Training was applied two days a week (Group 1-2: Tuesday, Group 3: Thursday) in order to ensure that the patients could get more benefit from the application.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being between the ages of 18-65,
* Having been diagnosed with Schizophrenia for at least 6 months according to ICD-10,
* Being registered with Selçuk University Medical Faculty Hospital Mental Health and Diseases Polyclinic,
* Coming to polyclinic check-ups regularly,
* Using antipsychotic medication regularly,
* Being at least a primary school graduate,

Exclusion Criteria

* • Having an organic mental disorder or mental retardation,

* Having a visual or hearing impairment,
* Participating in a program similar to the intervention to be implemented.
* Not attending at least two sessions of Psychosocial Skills Training,
* Having an exacerbation period/hospitalization and experiencing a physical discomfort at a level that prevents attending sessions during the program process,
* Wanting to leave the study,
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Selçuk University

UNKNOWN

Sponsor Role collaborator

Neslihan Lok

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Neslihan Lok

Prof. Dr. Study Director

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neslihan LÖK, Prof. Dr.

Role: STUDY_DIRECTOR

Selcuk University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Selcuk University Faculty of Medicine Hospital

Konya, Selçuklu, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SELCUKU-ANCANDAN-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Relapse Management Group Psychoeducation Program
NCT07327944 NOT_YET_RECRUITING NA